✦ LIBER ✦

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial

✍ Scribed by Michael W. Konstan; Patrick A. Flume; Matthias Kappler; Raphaël Chiron; Mark Higgins; Florian Brockhaus; Jie Zhang; Gerhild Angyalosi; Ellie He; David E. Geller

Book ID: 119288808
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 290 KB
Volume: 10
Category: Article
ISSN: 1569-1993
DOI: 10.1016/j.jcf.2010.10.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment convenience and satisfaction o

Treatment convenience and satisfaction of tobramycin inhalation powder (TIP) versus TOBI in cystic fibrosis (CF) patients

✍ D.E. Geller; P.A. Flume; F. Brockhaus; J. Zhang; G. Angyalosi; E. He; M. Konstan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Efficacy and safety of tobramycin and co

Efficacy and safety of tobramycin and colistin for inhalation in children with cystic fibrosis from Moscow region

✍ V.S. Nikonova; N.Y. Kashirskaya; N.I. Kapranov 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

323 Association of treatment satisfactio

323 Association of treatment satisfaction and compliance of cystic fibrosis (CF) patients using inhaled tobramycin treatment in the EAGER study

✍ A. Regnault; M.-M. Balp; K. Kulich; L. Estève; M. Viala-Danten 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Systematic review of the dry powder inha

Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis

✍ Uttley, L.; Harnan, S.; Cantrell, A.; Taylor, C.; Walshaw, M.; Brownlee, K.; Tap 📂 Article 📅 2013 🏛 European Respiratory Society 🌐 English ⚖ 427 KB

This systematic review evaluated evidence for two dry powder formulations, colistimethate sodium and tobramycin, for the treatment of chronic __Pseudomonas aeruginosa__ in cystic fibrosis, as part of the UK national recommendation process for new technologies. Electronic bibliographic databases were

67 Trends in health-related quality of l

67 Trends in health-related quality of life (HRQoL) in cystic fibrosis with tobramycin inhalation powder: the EDIT trial

✍ A.L. Quittner; M. Higgins; G. Angyalosi; F. Brockhaus; K. Thomas; J. Zhang 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Safety and efficacy of tobramycin inhala

Safety and efficacy of tobramycin inhalation powder (TIP) in treating CF patients infected with Pseudomonas aeruginosa (Pa)

✍ M. Konstan; P.A. Flume; F. Brockhaus; G. Angyalosi; E. He; D. Geller 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB